DISCOUNT OPTIONSSCHEIN - MEDTRONIC Stock

Certificat

DE000MB8MAX2

Market Closed - Börse Stuttgart 02:31:12 2024-05-24 pm EDT
0.02 EUR 0.00% Intraday chart for DISCOUNT OPTIONSSCHEIN - MEDTRONIC
Current month-9.09%
1 month+11.11%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-24 0.02 0.00%
24-05-23 0.02 -16.67%
24-05-22 0.024 0.00%
24-05-21 0.024 -4.00%
24-05-20 0.025 -7.41%

Delayed Quote Börse Stuttgart

Last update May 24, 2024 at 02:31 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying MEDTRONIC PLC
Issuer Morgan Stanley
WKN MB8MAX
ISINDE000MB8MAX2
Date issued 2023-07-12
Strike 97.5 $
Maturity 2024-06-21 (27 Days)
Parity 10 : 1
Emission price 0.19
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.33
Lowest since issue 0.013

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
82.29 USD
Average target price
94.77 USD
Spread / Average Target
+15.17%
Consensus